ArticleMolecular cancer research : MCR2016

Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer.

Jae-Young Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.